Publication | Open Access

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

Mito 11MedicineMetronomic TherapyGynecologyWeekly PaclitaxelCancer TreatmentOncologyRadiation OncologyGynecology OncologyMolecular OncologyOvarian Cancer